ACM
ISEE

Asymmetry Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Asymmetry Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$6.29M Buy
375,989
+20,593
+6% +$338K 3.34% 16
2021
Q3 		$5.77M Buy
+355,396
New +$3.87M 3.47% 15

Other funds holding ISEE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Asymmetry Capital Management's ISEE Position: Q4 2021 in Review

Asymmetry Capital Management increased its IVERIC bio, Inc. Common Stock (ISEE) stake by 5.8% in Q4 2021, buying an estimated $338K and bringing the position to 375,989 shares worth $6.29M. The position accounts for 3.34% of the portfolio, ranked #16.

Asymmetry Capital Management first reported a position in ISEE in Q3 2021 and has held it in 2 quarters since. 175 funds tracked by Wall St. Rank hold ISEE as of Q4 2021.

  • Asymmetry Capital Management held 375,989 shares of IVERIC bio, Inc. Common Stock worth $6.29M as of Q4 2021.
  • Asymmetry Capital Management bought 20,593 IVERIC bio, Inc. Common Stock shares in Q4 2021, an estimated $338K.
  • IVERIC bio, Inc. Common Stock made up 3.34% of Asymmetry Capital Management's portfolio in Q4 2021, its #16 holding.
  • Asymmetry Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q3 2021 and has held it in 2 quarters since.
  • 175 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2021.

Based on Asymmetry Capital Management's 13F filing for Q4 2021, filed 19 Jan 2022.